Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-04 Sale |
2021-02-05 4:41 pm |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
969 | $11.21 | $10,862 | 104,341 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:40 pm |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
1,021 | $11.21 | $11,445 | 53,465 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:40 pm |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
227 | $11.21 | $2,545 | 13,431 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:36 pm |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
894 | $11.21 | $10,022 | 83,188 (Direct) |
View |
| 2021-02-04 Sale |
2021-02-05 4:32 pm |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
817 | $11.21 | $9,159 | 52,685 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:44 pm |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
6,069 | $11.41 | $69,247 | 248,367 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:42 pm |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
2,872 | $11.41 | $32,770 | 55,957 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:42 pm |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
599 | $11.41 | $6,835 | 27,982 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:38 pm |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
2,872 | $11.41 | $32,770 | 75,727 (Direct) |
View |
| 2020-12-03 Sale |
2020-12-07 07:00 am |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
2,522 | $13.54 | $34,148 | 76,089 (Direct) |
View |
| 2020-11-11 Purchase |
2020-11-13 07:05 am |
Epizyme Inc. | EPZM | GOLDFISCHER CARL Director |
5,000 | $12.07 | $60,350 | 3,385,951 (Indirect Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 09:04 am |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
317 | $16.15 | $5,120 | 4,838 (Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 09:01 am |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
4,773 | $16.15 | $77,084 | 250,098 (Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 08:57 am |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
1,805 | $16.15 | $29,151 | 21,942 (Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 08:56 am |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
1,805 | $16.15 | $29,151 | 78,611 (Direct) |
View |
| 2020-06-26 Sale |
2020-06-30 08:54 am |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
2,728 | $16.15 | $44,057 | 57,507 (Direct) |
View |
| 2020-06-26 Purchase |
2020-06-26 7:12 pm |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
62,019 | $16.03 | $994,165 | 189,560 (Indirect Direct) |
View |
| 2020-06-18 Sale |
2020-06-22 7:36 pm |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
20,000 | $22 | $440,000 | 567,704 (Direct) |
View |
| 2020-06-18 Sale |
2020-06-22 7:31 pm |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
112,003 | $21.24 | $2,378,444 | 374,719 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-01 Option Award |
2021-02-02 9:12 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
170,718 | $0 | 246,445 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:09 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
504,943 | $0 | 753,310 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:08 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
19,250 | $0 | 25,208 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:07 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
150,280 | $0 | 178,725 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:05 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
147,274 | $0 | 175,256 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:05 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
162,303 | $0 | 218,260 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 9:01 pm |
N/A 2031-01-31 |
Epizyme Inc. | EPZM | Kutok Jeffery Chief Scientific Officer |
165,308 | $0 | 192,720 (Direct) |
View |
Ownership(A) |
2021-01-27 8:31 pm |
N/A N/A |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
0 | $0 | 28,581 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 08:32 am |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
1,024 | $10.86 | 9,559 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 08:15 am |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
2,158 | $10.86 | 195,142 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-01 4:58 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
1,965 | $11.93 | 192,984 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-01 4:56 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
933 | $11.93 | 8,535 (Direct) |
View |
| 2020-09-22 Option Award |
2020-09-28 4:15 pm |
N/A 2030-09-21 |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-09-28 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | Vakiener Victoria Chief Commercial Officer |
0 | $0 | 208,424 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
7,055 | $0 | 48,068 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-21 4:15 pm |
N/A N/A |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
2,091 | $12.55 | 48,068 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 5:04 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
1,459 | $16.06 | 191,019 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 4:32 pm |
N/A N/A |
Epizyme Inc. | EPZM | Conroy Kevin T Director |
693 | $16.06 | 7,602 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 09:04 am |
N/A N/A |
Epizyme Inc. | EPZM | Beaulieu Joseph Corporate Controller |
1,050 | $0 | 4,838 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 09:01 am |
N/A N/A |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
10,500 | $0 | 250,098 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 08:57 am |
N/A N/A |
Epizyme Inc. | EPZM | TOMBESI PAOLO Chief Financial Officer |
6,000 | $0 | 21,942 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 08:56 am |
N/A N/A |
Epizyme Inc. | EPZM | Agarwal Shefali Chief Medical Officer |
6,000 | $0 | 78,611 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-30 08:54 am |
N/A N/A |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
6,000 | $0 | 57,507 (Direct) |
View |
| 2020-06-18 Other |
2020-06-22 7:39 pm |
N/A N/A |
Epizyme Inc. | EPZM | MOTT DAVID M Director |
67,662 | $0 | 195,203 (Indirect) |
View |
| 2020-06-18 Exercise |
2020-06-22 7:36 pm |
N/A 2026-02-07 |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
10,000 | $0 | 567,704 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 7:36 pm |
N/A N/A |
Epizyme Inc. | EPZM | Bazemore Robert B President & CEO |
10,000 | $8.98 | 567,704 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 7:31 pm |
N/A 2029-01-23 |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
112,003 | $0 | 374,719 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 7:31 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
2,289 | $12.45 | 374,719 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 7:31 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
41,063 | $9.12 | 374,719 (Direct) |
View |
| 2020-06-18 Exercise |
2020-06-22 7:31 pm |
N/A N/A |
Epizyme Inc. | EPZM | Ros Matthew See Remarks |
68,651 | $9.58 | 374,719 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:23 pm |
2021-05-29 2029-05-29 |
Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner |
14,103 | $0 | 9,215,178 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:19 pm |
N/A 2030-05-28 |
Epizyme Inc. | EPZM | Giordano Michael F Director |
14,013 | $0 | 14,013 (Direct) |
View |
| 2020-05-29 Option Award |
2020-06-02 4:17 pm |
N/A 2030-05-28 |
Epizyme Inc. | EPZM | Allen Andrew R Director |
14,013 | $0 | 14,013 (Direct) |
View |